Popular COVID Drug Remdesivir to cause adverse effects, flagged by IPC - Video

Published On 2022-01-06T13:53:38+05:30 | Updated On 7 Jan 2022 12:49 PM IST

Overview

Covid -19 treatment has been challenging since 2020, new drugs are evaluated to control the novel corona virus. Remdesivir (GS-5734), an inhibitor of the viral RNA-dependent, RNA polymerase with in vitro inhibitory activity against SARS-CoV-1 was a promising therapeutic candidate for Covid-19 because of its ability to inhibit SARS-CoV-2 in vitro, however its safety is yet to be evaluated.

The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of December, has revealed that popular Covid-19 drug Remdesivir is associated with Adverse Drug Reactions (ADRs) named Sinus Bradycardia.

This came after preliminary analysis of Adverse Drug Reactions (ADRs) from the Pharmacovigilance Programme of India (PvPI) database

with the gathered data IPC cautions health care professionals to closely monitor the ADRs of the drug for further safety.,

For more information check out the full story on the link below:

IPC flags adverse reaction linked to popular COVID drug Remdesivir

Speakers

Roshni Dhar

Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751